KRTX News
Archived Headlines
- Adaptive Bio Offers Next Gen Cancer Tests 06/25/19
- June's flood of biotech IPOs continues with these 4 deals 06/24/19
- US IPO Week Ahead: Tech and big biotech fill up a 9-IPO week 06/21/19
- June is getting a flood of biotech IPOs with these 9 deals on the calendar 06/18/19
- Schizophrenia biotech Karuna Therapeutics sets terms for $70 million IPO 06/17/19
See more
US IPO Week Ahead: The IPO market takes its holiday vacation
There are no companies scheduled for the holiday week ahead, and we likely won’t see any more IPOs until 2020. Lock-up periods will be expiring for seven companies. On Monday, December 23: Cambium Networks (CMBM). On Tuesday,...read more
Monthly movers: 4 recent biotech IPOs soar more than 100%, 4 drop more than 50%
Four recent biotech IPOs have soared more than 100% in the last 30 days, while four others have seen their stock prices halved. The highest flyer is June 2019 IPO Karuna Therapeutics (KRTX), up 282% over the past 30 days. In mid-November,...read more
US IPO Weekly Recap: Big biotechs score big as Adaptive soars 142%
Eight companies raised $2.1 billion this past week, capping off the US IPO market's largest quarter in five years. The week was split between tech and biotechs, including two in the biotech space that went public at valuations of more than $2.0 billion. Over 10...read more
Schizophrenia biotech Karuna Therapeutics prices IPO at $16 midpoint
Karuna Therapeutics, a Phase 2 biotech developing therapies for schizophrenia and other CNS disorders, raised $89 million by offering 5.6 million shares at $16, the midpoint of the $15 to $17 range. It had previously filed to offer 4.4 million shares. Karuna...read more